Sign in

CIK 0001527352 · <br>Emerging growth company

Nexalin Technology, Inc.

Sign in to watch
Ticker
NXL
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275566468
Phone
(832) 260-0222
Business address
1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
  1. S-1/A Offering Registration Statement
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. 4 Open-market buy Chief Medical Officer bought 1,619 shares at $0.71 ($1,149)
  5. 8-K Event Other events
  6. S-1/A Offering Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $0.64 ($1,920)
  9. UPLOAD Other SEC-generated Letter
  10. S-1 Offering Registration Statement
  11. 8-K Event Delisting notice
  12. RW Other RW
  13. 10-Q Report Quarterly Report
  14. 8-K Event Other events
  15. S-3 Offering Registration Statement
  16. 8-K Event Other events
  17. 10-K Report Annual Report
  18. 8-K Event Shareholder vote results
  19. DEF 14A Proxy Proxy Statement
  20. 10-Q Report Quarterly Report

Page 7 of 11 · 206 filings